CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +805,500 | 805,500 | ||
| 2025-08-01 | McKinley Kate Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-05-23 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2024-12-13 | McKinley Kate Chief Business Officer | Purchase | +17,960 | $1.67 | $30K | 17,960 |
| 2024-03-21 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +323,500 | 323,500 | ||
| 2023-12-16 | McKinley Kate Chief Business Officer | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | ||
| 2023-12-16 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-05-22 | McKinley Kate CHIEF BUSINESS OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 |
Page 1 of 1 · 8 trades